Mesothelioma Clinical Trials Overview > Mesothelioma Clinical Trial List
Pharmacokinetic, Safety, and Efficacy Effects of Oral LBH589 on Dextromethorphan in Patients With Advanced or Metastatic Non-Small Cell Lung Cancer or Malignant Pleural Mesothelioma
| Conditions: | Carcinoma, Non-Small-Cell Lung|Mesothelioma |
| Start Date: | November 1, 2007 |
| Phase: | Phase I |
| Status: | Completed |
| NCT ID: | NCT00535951 |
| Study Type: | Interventional |
| Intervention: | Drug: LBH589 |
| Study Design: | Allocation: Non-Randomized|Control: Active Control|Endpoint Classification: Safety/Efficacy Study|Intervention Model: Single Group Assignment|Masking: Open Label|Primary Purpose: Treatment |
| Results: | No Results Available |
| Sponsors: | Novartis Pharmaceuticals |
| Ages: | Adult|Senior |
| Enrollment: | 18 |
| Funded By: | Industry |
| First Received: | September 26, 2007 |
| End Date: | |
| Last Updated: | January 14, 2010 |
| Last Verified: | January 1, 2010 |
Mesothelioma
Lawsuit Evaluation
Lawsuit Evaluation
